New award for metolazone tablets with golden state medical supply, INC. Period of performance is AUG 24, 2021 to AUG 23, 2022 with four one-year options

Ended Indefinite Delivery Contract Awarded Last action

Contract number
36E79721D0045
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 100% complete
IDV ceiling
$3,413,993.75
Award type
Single award
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The National Acquisition Center awarded a single-award indefinite-delivery contract to Golden State Medical Supply, Inc. for metolazone tablets on August 24, 2021, with a ceiling value of $3,413,993.75. The contract carries no set-aside designation.

The period of performance runs from August 24, 2021 through August 23, 2022, with four one-year options extending the ultimate completion date to August 23, 2026. Golden State Medical Supply, Inc. is a pharmaceutical manufacturer and distributor based in Camarillo, California, supplying essential medications to federal healthcare systems including the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. The originating solicitation was posted as a pre-solicitation notice on April 23, 2021, with an initial due date of April 22, 2021 and award issued four months later. The contract was established to provide uninterrupted metolazone tablet supplies through a prime vendor program serving federal healthcare facilities nationwide.

Transactions

Action Obligated Date
Other Administrative Action P00007 · To change the administrative and sales point of contact $0
Exercise an Option P00006 · Exercise the fourth and final option year for metolazone tablets contract 36E79721D0045 with golden state medical supply, INC. With no price changes $0
Exercise an Option P00005 · Exercise the third option year for metolazone tablets contract 36E79721D0045 with golden state medical supply, INC. With no price changes $0
Supplemental Agreement for work within scope P00004 · Change timeframe for the submission of quarterly sales reports and cost recovery fee to 30 calendar days after end of each fiscal quarter. $0
Exercise an Option P00003 · Exercise option year 2 effective august 24, 2023 to august 23, 2024 for metolazone tablets with golden state medical supply, INC. With no price change. $0
Other Administrative Action P00002 · Incorporation of drug supply chain security act (DSCSA) language $0
Exercise an Option P00001 · Exercise option year 1 for metolazone tablets. Period of performance is AUG 24, 2022 to AUG 23, 2023. $0
Original award $0

Quick answers

Who was awarded contract 36E79721D0045?

36E79721D0045 was awarded to Golden State Medical Supply, Inc. by National Acquisition Center (Headquarters) on August 24, 2021.

How much is contract 36E79721D0045 worth?

36E79721D0045's own ceiling is $3,413,994.

Who can order from contract 36E79721D0045?

36E79721D0045 is a single award indefinite delivery contract.

Was contract 36E79721D0045 competed?

The extent of competition for 36E79721D0045 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV